RxDoctor Payments Data

Chelsea Centurioni, PA

Physician Assistant · Schenectady, NYNPI 1013463686

Payments from drug & device makers

$3,594in general payments, 2019–2025

Across 160 payments — averaging $22.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$441
  • Harmony Biosciences LLC$401
  • Regeneron Healthcare Solutions, Inc.$250
  • Amgen$245
  • Boehringer Ingelheim$240
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$251%
  • Food & beverage$3,46997%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,594 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$29,858
Medicare patients
130
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter148$125,761
Dupixent PenDupilumab12$42,900
Breztri AerosphereBudesonide/Glycopyr/Formoterol54$38,161
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr53$28,521
Breo ElliptaFluticasone/Vilanterol39$20,077
Spiriva RespimatTiotropium Bromide31$19,030
SymbicortBudesonide/Formoterol Fumarate57$17,498
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate61$11,788
Fluticasone-SalmeterolFluticasone Propion/Salmeterol83$7,476
BreynaBudesonide/Formoterol Fumarate34$7,446
Albuterol Sulfate HfaAlbuterol Sulfate143$3,724
Roflumilast22$1,739
Fluticasone Propionate35$1,007
Prednisone100$417
Omeprazole38$330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$1,016$174,359240 claims
AstraZenecaBreztri Aerosphere, Symbicort$441$55,659111 claims
Boehringer IngelheimSpiriva Respimat$240$19,03031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Schenectady

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →